MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1097/aog.0000000000004826

Медицинская библиотека · Obstetrics and gynecology · 2022

Outpatient Use of Monoclonal Antibodies in Pregnant Individuals With Mild or Moderate Coronavirus Disease 2019 (COVID-19).

Eid Joe, Abdelwahab Mahmoud, Williams Hayley, Lehman Joy, Malvestutto Carlos, Landon Mark B, Costantine Maged M, Rood Kara M

Письмо в редакциюПеревод пока не подготовлен

Аннотация

Treatment with monoclonal antibodies has been shown to significantly reduce the risk of hospitalization and disease progression among high-risk patients with coronavirus disease 2019 (COVID-19). Pregnant individuals were excluded from the original trials. In this single-center retrospective cohort study, we evaluated whether monoclonal antibody treatment in pregnant individuals is associated with decreased risk of hospitalization. Outcomes of patients who received the treatment were compared with those who were eligible but did not receive the treatment. Analyses were stratified by vaccination status. Unvaccinated pregnant patients with mild or moderate COVID-19 who received outpatient monoclonal antibodies were less likely to be admitted to the hospital (4.2% vs 15.7%, odds ratio 0.24, 95% CI 0.07-0.74), whereas among vaccinated patients, the treatment was not associated with a lower rate of hospitalization (2.3% vs 0%, P=.99).

Для цитирования: Eid Joe, Abdelwahab Mahmoud, Williams Hayley, Lehman Joy, Malvestutto Carlos, Landon Mark B, Costantine Maged M, Rood Kara M. Outpatient Use of Monoclonal Antibodies in Pregnant Individuals With Mild or Moderate Coronavirus Disease 2019 (COVID-19).. Obstetrics and gynecology. 2022. DOI: 10.1097/aog.0000000000004826.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.